메뉴 건너뛰기




Volumn 19, Issue 6, 2004, Pages 1629-1633

Bilateral primary renal lymphoma treated by surgery and chemotherapy

Author keywords

Chemotherapy; Chronic renal failure; Hypercalcaemia; Nephrectomy; Primary renal lymphoma

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; FLUDARABINE; FOLINIC ACID; FUROSEMIDE; METHOTREXATE; PREDNISOLONE; VINCRISTINE;

EID: 2942741051     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfh250     Document Type: Article
Times cited : (29)

References (10)
  • 3
    • 0030898012 scopus 로고    scopus 로고
    • Bilateral primary renal non-Hodgkin's lymphoma presenting with acute renal failure. Successful treatment with systemic chemotherapy
    • Chio JH, Choi GB, Shim KN, Sung SH, Han WS, Back SY. Bilateral primary renal non-Hodgkin's lymphoma presenting with acute renal failure. Successful treatment with systemic chemotherapy. Acta Haematol 1997; 97: 231-235
    • (1997) Acta Haematol. , vol.97 , pp. 231-235
    • Chio, J.H.1    Choi, G.B.2    Shim, K.N.3    Sung, S.H.4    Han, W.S.5    Back, S.Y.6
  • 6
    • 0028214379 scopus 로고
    • Primary renal lymphoma. Report of 3 cases and review of the literature
    • Arjia JAA, Carrion JR, Garcia F et al. Primary renal lymphoma. Report of 3 cases and review of the literature. Am J Nephrol 1994; 14: 148-153
    • (1994) Am. J. Nephrol. , vol.14 , pp. 148-153
    • Arjia, J.A.A.1    Carrion, J.R.2    Garcia, F.3
  • 7
    • 0032843056 scopus 로고    scopus 로고
    • An advantageous method to evaluate IgH rearrangement and its role in minimal residual disease
    • Galimberti S, Brizzi F, Mameli M, Petrini M. An advantageous method to evaluate IgH rearrangement and its role in minimal residual disease. Leukemia Res 1999; 23: 921-929
    • (1999) Leukemia Res. , vol.23 , pp. 921-929
    • Galimberti, S.1    Brizzi, F.2    Mameli, M.3    Petrini, M.4
  • 8
    • 0031763077 scopus 로고    scopus 로고
    • Long-term follow-up non-Hodgkin's lymphoma patients treated with ProMACE-CytaBOM: An effective regimen for intermediate grade subtype
    • Marotta G, Bigazzi C, Bocchia M et al. Long-term follow-up non-Hodgkin's lymphoma patients treated with ProMACE-CytaBOM: an effective regimen for intermediate grade subtype. Haematologica 1998; 83: 853-854
    • (1998) Haematologica , vol.83 , pp. 853-854
    • Marotta, G.1    Bigazzi, C.2    Bocchia, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.